Skip to main content

Table 1 The basic clinic-pathological features of OvCa patients in two datasets

From: Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico

Characteristics

n

Cases (%)

GSE49997

GSE9891

Histologic subtype

 Serous

435

171 (88.1%)

264 (92.6%)

 Non-serous

44

23 (11.9%)

21 (7.4%)

FIGO stage

 Stage 1

24

0 (0%)

24 (8.4%)

 Stage 2

27

9 (4.6%)

18 (6.3%)

 Stage 3

371

154 (79.4%)

217 (76.1%)

 Stage 4

53

31 (16.0%)

22 (7.7%)

 Unknown

4

0 (0%)

4 (1.4%)

Grade

 Grade 1

30

11 (5.7%)

19 (6.7%)

 Grade 2

136

39 (20.1%)

97 (34.0%)

 Grade 3

307

143 (73.7%)

164 (57.5%)

 Unknown

6

1 (0.5%)

5 (1.8%)

Residual tumor

 No

221

137 (70.6%)

84 (29.5%)

 Yes

221

57 (29.4%)

164 (57.5%)

 Unknown

37

0 (0%)

37 (13.0%)